Monitor for actual share issuance under the ATM program, as any sales will be immediately dilutive. The company's high cash burn suggests issuance is likely, which could pressure the stock price. Consider short opportunities if issuance begins.
Price Chart
Executive Summary
ProMIS Neurosciences filed an S-3 shelf registration allowing it to raise up to $200 million through various securities, including a $50 million ATM offering with H.C. Wainwright. This signals potential share issuance, which is dilutive given the company's $38 million market cap. The offering will fund clinical development of PMN310 and general corporate needs.
Key Financial Metrics
Key Facts
- Company filed S-3 shelf registration allowing issuance of up to $200 million in securities
- Specific $50 million ATM offering with H.C. Wainwright for common shares at up to 3% commission
- Company market cap is $38 million, making the $50 million offering highly dilutive (132% of market cap)
- Proceeds to be used for PMN310 clinical development and general corporate purposes
- Recent 10-Q shows net loss of $29 million for nine months ending September 2025
- Company has substantial cash burn and negative cash flow from operations
Financial Impact
Up to $50 million in potential dilution from ATM offering, representing 132% of current $38 million market cap
Risk Factors
- Significant dilution to existing shareholders
- Potential downward pressure on stock price from continuous share issuance
- Company's ability to raise capital depends on maintaining minimum stock price requirements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-034613 |
| Document: pmn-20260325xex4d3.htm | 0001104659-26-034613 |
| Document: pmn-20260325xex5d1.htm | 0001104659-26-034613 |
| Document: pmn-20260325xexfees.htm | 0001104659-26-034613 |
| Document: pmn-20260325xex5d2.htm | 0001104659-26-034613 |
| Document: pmn-20260325xex23d1.htm | 0001104659-26-034613 |
| Document: 0001104659-26-034613-index-headers.html | 0001104659-26-034613 |
| Document: 0001104659-26-034613-index.html | 0001104659-26-034613 |
| Document: 0001104659-26-034613.txt | 0001104659-26-034613 |
| CONTEXT: 10-Q (2025-11-12) | 0001104659-25-109719 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 3 | $9.12 $9.15 | ▲ +0.33% | ▲ +0.75% | $9.18 (+0.60%) |
Oct 6, 2026 21d ago | Press Release | $9.21 $9.12 | ▼ −0.98% | ▼ −0.74% | $9.18 (−0.38%) |
Sep 1, 2026 8w ago | Press Release | $13.35 $13.98 | ▲ +4.68% | ▲ +4.24% | $9.18 (−31.27%) |
Jul 14, 2026 15w ago | Press Release | $13.66 $14.01 | ▲ +2.53% | ▲ +2.13% | $9.18 (−32.83%) |
May 28, 2026 21w ago | Press Release | $10.87 $10.81 | ▼ −0.55% | ▼ −0.79% | $9.18 (−15.59%) |
May 12, 2026 24w ago | 8-K | $10.49 $10.57 | ▲ +0.76% | ▲ +0.19% | $9.18 (−12.54%) |
Apr 3, 2026 29w ago | EFFECT | $10.96 $10.88 | ▲ +0.73% | ▲ +0.79% | $9.18 (+16.29%) |
Mar 25, 2026 30w ago | S-3 | $15.13 $14.74 | ▲ +2.58% | ▲ +0.90% | $9.18 (+39.36%) |
Mar 18, 2026 31w ago | S-3 | $18.21 $17.60 | ▲ +3.35% | ▲ +1.61% | $9.18 (+49.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers